Enact Acquires Rights To Cytoxic, Prepares To File For Approvals May 22, 2002 By Nuala Moran No Comments
Ark Delays Initial Public Offering Due To Unfavorable Conditions May 22, 2002 By Nuala Moran No Comments LONDON - Ark Therapeutics Group plc postponed its initial public offering on the London Stock Market, blaming "unusually adverse market conditions." (BioWorld International)Read More
CAT Releases Positive Follow-Up Results In Phase II CAT-152 Trial May 15, 2002 By Nuala Moran No Comments
CAT Releases Positive Follow-Up Results In Phase II CAT-152 Trial May 15, 2002 By Nuala Moran No Comments
